Assessing the Consequences of External Reference Pricing for Global Access to Medicines and Innovation: Economic Analysis and Policy Implications

• Главные авторы: András Incze (Автор), Zoltán Kaló (Автор), Jaime Espín (Автор), Éva Kiss (Автор), Sophia Kessabi (Автор), Louis P. Garrison (Автор)
• Формат: ‌
• Опубликовано: Frontiers Media S.A., 2022-04-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Background: External reference pricing (ERP) is used to set pharmaceutical prices to improve affordability, but its application may have negative consequences on patient access-thus, equity-across countries and on global innovation. With the United States contemplating ERP, negative effects could be...